Literature DB >> 7505040

Diagnostic value of bone marrow biopsy in patients with renal disease secondary to familial Mediterranean fever.

C Sungur1, A Sungur, S Ruacan, N Arik, U Yasavul, C Turgan, S Caglar.   

Abstract

Systemic AA type amyloidosis with renal involvement is the major cause of morbidity and mortality in patients with familial Mediterranean fever (FMF). A histopathological examination is essential to achieve a definite diagnosis in systemic amyloidosis. The diagnostic yield of the procedure varies according to the biopsy site and renal biopsy has the highest yield. On the other hand this procedure has its own complications and requires hospitalization of the patient. Alternative biopsy sites have been proposed with varying degrees of sensitivity and morbidity to reduce the morbidity and mortality of solid organ biopsies. We performed bone marrow biopsies in 39 patients with FMF who had different stages of renal disease. Thirty-one (79.5%) of the 39 specimens showed significant perivascular amyloid infiltration when stained with crystal violet and Congo red. An immunoperoxidase stain with a monoclonal antibody proved that these deposits were AA type amyloid. We suggest that bone marrow biopsy can be utilized for a safe and quick diagnosis of systemic amyloidosis in patients with FMF and renal disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505040     DOI: 10.1038/ki.1993.318

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  A case of primary (AL) amyloidosis with predominantly vascular amyloid deposition in the kidney.

Authors:  Yoichi Murakami; Soken Hattori; Fumiko Sugiyama; Kazuyuki Yoshikawa; Takeshi Sugiura; Hideki Matsushima
Journal:  CEN Case Rep       Date:  2014-12-02

Review 2.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

3.  Spontaneous regression of bilateral surrenal haematoma and subclinical hypoaldosteronism in a patient with renal amyloidosis secondary to Familial Mediterranean Fever.

Authors:  S Paydaş
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

4.  Adrenal axis functions in patients with familial Mediterranean fever.

Authors:  Tansu Sav; Sav Tansu; Omer Ozbakir; Ozbakir Omer; Fahrettin Kelestimur; Kelestimur Fahrettin; Sebnem Gursoy; Gursoy Sebnem; Mevlut Baskol; Baskol Mevlut; Mustafa Kula; Kula Mustafa; Munis Dundar; Dundar Munis
Journal:  Clin Rheumatol       Date:  2005-11-03       Impact factor: 2.980

Review 5.  [Bone marrow histology from the clinical point of view].

Authors:  T Seiler; M Dreyling
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

6.  Is there a role for 18F-FDG PET-CT in Familial Mediterranean fever? A case report and overview of the literature.

Authors:  A Abdalla Ibrahim; P Smeets; I Goethals
Journal:  Radiol Case Rep       Date:  2021-04-30

Review 7.  Renal amyloidosis in children.

Authors:  Yelda Bilginer; Tekin Akpolat; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2011-03-01       Impact factor: 3.714

8.  Familial Mediterranean fever; diagnosis, treatment, and complications.

Authors:  Bahman Bashardoust
Journal:  J Nephropharmacol       Date:  2015-01-01

Review 9.  From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature.

Authors:  Magdalena Dziadzio; Constantinos P Anastassiades; Philip N Hawkins; Michael Potter; Armando Gabrielli; Geraldine M Brough; Carol M Black; Christopher P Denton
Journal:  Clin Rheumatol       Date:  2005-03-02       Impact factor: 2.980

10.  Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients.

Authors:  Normann Steiner; Georg Göbel; Hannes Neuwirt; Eberhard Gunsilius; Patricia Suchecki; Wolfgang Prokop
Journal:  Oncotarget       Date:  2017-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.